Technical Analysis for ATOS - Atossa Genetics Inc.

Grade Last Price % Change Price Change
grade F 1.3683 0.61% 0.01
ATOS closed down 0.73 percent on Wednesday, February 19, 2020, on 54 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ATOS trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.61%
Outside Day Range Expansion 0.61%
Down 3 Days in a Row Weakness 0.61%
Down 4 Days in a Row Weakness 0.61%
Lower Bollinger Band Touch Weakness 0.61%
Lower Bollinger Band Walk Weakness -0.12%
Inside Day Range Contraction -0.12%
Down 3 Days in a Row Weakness -0.12%
Lower Bollinger Band Touch Weakness -0.12%
Hammer Candlestick Bullish -0.85%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65; and the ArgusCYTE Breast Health Test that offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company also intends to offers FullCYTE Breast Health Test, which is in development to assess the individual breast ducts for pre-cancerous changes in women; and NextCYTE Breast Cancer Test that is in the prevalidation phase to profile breast cancer specimens for prediction of treatment outcomes and distant recurrence in women newly diagnosed with breast cancer. Atossa Genetics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.
Medicine Health Cancer Healthcare Breast Cancer Diagnostic Tests Breast Implant Breast Surgery

Is ATOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.39
52 Week Low 1.19
Average Volume 83,038
200-Day Moving Average 1.90
50-Day Moving Average 1.51
20-Day Moving Average 1.46
10-Day Moving Average 1.43
Average True Range 0.08
ADX 22.7
+DI 11.08
-DI 26.98
Chandelier Exit (Long, 3 ATRs ) 1.34
Chandelier Exit (Short, 3 ATRs ) 1.53
Upper Bollinger Band 1.58
Lower Bollinger Band 1.35
Percent B (%b) 0.06
BandWidth 16.08
MACD Line -0.04
MACD Signal Line -0.03
MACD Histogram -0.0122
Fundamentals Value
Market Cap 15.92 Million
Num Shares 11.7 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -0.70
Price-to-Sales 0.00
Price-to-Book 2.23
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.50
Resistance 3 (R3) 1.49 1.45 1.47
Resistance 2 (R2) 1.45 1.41 1.45 1.46
Resistance 1 (R1) 1.40 1.39 1.43 1.41 1.46
Pivot Point 1.36 1.36 1.37 1.36 1.36
Support 1 (S1) 1.31 1.32 1.34 1.32 1.26
Support 2 (S2) 1.27 1.30 1.27 1.26
Support 3 (S3) 1.22 1.27 1.25
Support 4 (S4) 1.23